ALK mutations or gene amplification are present in up to 15% of sporadic high-risk neuroblastomas, the most common somatic single-nucleotide variant in neuroblastoma and the most frequently mutated oncogene (Figure 1). The gene discussed is ALK; the disease is neuroblastoma.